Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2025 Results And Provides Corporate Update
| For the quarter ended: | ||||||
| August 31, 2025 (Q4 2025) | May 31, 2025 (Q3 2025) | % change | ||||
| Total Revenue | $2,325,321 | $1,802,942 | 29.0% | |||
| Cost of revenue | 902,926 | 932,842 | -3.2% | |||
| Gross Profit (Loss) | $1,422,395 | $870,100 | 63.5% | |||
| Gross profit margin (loss) | 61.2% | 48.3% | 2680 bps | |||
| Operating expenses and other items | 2,882,259 | 1,667,279 | 71.8% | |||
| Loss and comprehensive loss | ($881,837) | ($741,575) | n/a |
Numinus' consolidated financial statements for the year ended August 31, 2025, and related management's discussion and analysis are available on Numinus' Investor Relations website at and under the Company's profile on SEDAR+ at . These documents were prepared in accordance with IFRS.
Financial Reporting Update
The Company continues to advise that the completion of the August 31, 2025, audit, together with the imminent filing of the Company's outstanding interim financial reports, is a central component of management's plan to satisfy the regulatory requirements necessary to have the cease trade order that is currently in place with respect to the Company (the“CTO”) revoked.
Management remains focused on completing the remaining interim financial reports, satisfying all regulatory requirements necessary to have the CTO revoked, and advancing the Company's previously announced application to list its common shares on the Canadian Securities Exchange (the "CSE"). Successfully executing these steps remains management's primary strategy to restore trading, enhance shareholder liquidity, and position the Company for its next phase of growth. A listing on the CSE will be contingent on the Company satisfying the CSE's listing requirements and being approved for listing on that exchange.
Board Appointment
The Company is pleased to announce the appointment of John Fong, former CFO of Numinus Wellness Inc., as a member of the Company's Board of Directors and the Board's Audit Committee. Following his departure from Numinus, Mr. Fong founded F28 Studio, a fractional CFO practice serving high-growth companies. F28 turns legacy tools and structures into intelligent systems using AI. Mr. Fong is an independent member of the Board of Directors and its Audit Committee, as well as being financially literate (among other reasons, in light of his prior experience as CFO of the Company).
About Numinus
Numinus Wellness Inc. (OTC Pink: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic research and training – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at and follow us on LinkedIn, Facebook, Twitter, and Instagram.
SOURCE Numinus Wellness Inc.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including, without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are "forward-looking statements". Forward-looking statements can be identified by the use of words such as "expects", "does not expect", "is expected", "believes", "intends", "anticipates", "does not anticipate", "believes" or variations of these words, expressions or statements, that certain actions, events or results "may", "could", "would", "might" or "will be" taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These and other risk factors are outlined in our annual information form dated July 25, 2025, which is available on SEDAR+ at . These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company's efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws.
For more information:
Investor Contact
Craig MacPhail
...
To view the source version of this press release, please visit
Source: Numinus Wellness Inc.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment